Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shourong Liu

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
RSC Medicinal Chemistry|May 4, 2026
Beyond acrylamide: a structure-guided investigation of covalent warheads in the development of CDK7 inhibitorsYu Cao, Yiqing Huang, Yunlong Pan, et al.
AIDS Research and Human Retroviruses|July 27, 2021
Comparing Noninvasive Predictors of Neurosyphilis Among Syphilis Patients With and Without HIV Co-Infection Based on the Real-World Diagnostic Criteria: A Single-Center, Retrospective Cohort Study in ChinaJun Yan, Lian Luo, Jie Han, et al.
Bioorganic & Medicinal Chemistry|April 17, 2017
Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitorsYanmei Zhao, Jiankang Zhang, Rangxiao Zhuang, et al.
Frontiers in Immunology|March 20, 2023
Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIVYi Wang, Jianhua Li, Wenhui Zhang, et al.
European Journal of Medicinal Chemistry|December 28, 2016
Exploration of novel piperazine or piperidine constructed non-covalent peptidyl derivatives as proteasome inhibitorsRangxiao Zhuang, Lixin Gao, Xiaoqing Lv, et al.
Virologica Sinica|May 24, 2025
Host factor RBM25 promotes HBV replication through Yin Yang 1-mediated cccDNA transcriptionYukun Li, Tianhao Mao, Liwei Zheng, et al.
BMC Infectious Diseases|August 10, 2021
Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in Hangzhou, ChinaJianjiang Qi, Di He, Dagan Yang, et al.
Life Science Alliance|October 19, 2022
A prediction model for COVID-19 liver dysfunction in patients with normal hepatic biochemical parametersJianfeng Bao, Shourong Liu, Xiao Liang, et al.
Clinical Complementary Medicine and Pharmacology|April 15, 2024
Treatment Effects of Integrated TCM and Western Medicine Treatment Scheme on COVID-19: A Single-armed Clinical TrialJianfeng Bao, Zhijun Xie, Shourong Liu, et al.
Gut|August 21, 2025
Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progressionXi Liang, Jinjin Luo, Qian Zhou, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
RSC Medicinal Chemistry|May 4, 2026
Beyond acrylamide: a structure-guided investigation of covalent warheads in the development of CDK7 inhibitorsYu Cao, Yiqing Huang, Yunlong Pan, et al.
AIDS Research and Human Retroviruses|July 27, 2021
Comparing Noninvasive Predictors of Neurosyphilis Among Syphilis Patients With and Without HIV Co-Infection Based on the Real-World Diagnostic Criteria: A Single-Center, Retrospective Cohort Study in ChinaJun Yan, Lian Luo, Jie Han, et al.
Bioorganic & Medicinal Chemistry|April 17, 2017
Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitorsYanmei Zhao, Jiankang Zhang, Rangxiao Zhuang, et al.
Frontiers in Immunology|March 20, 2023
Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIVYi Wang, Jianhua Li, Wenhui Zhang, et al.
European Journal of Medicinal Chemistry|December 28, 2016
Exploration of novel piperazine or piperidine constructed non-covalent peptidyl derivatives as proteasome inhibitorsRangxiao Zhuang, Lixin Gao, Xiaoqing Lv, et al.
Virologica Sinica|May 24, 2025
Host factor RBM25 promotes HBV replication through Yin Yang 1-mediated cccDNA transcriptionYukun Li, Tianhao Mao, Liwei Zheng, et al.
BMC Infectious Diseases|August 10, 2021
Severity-associated markers and assessment model for predicting the severity of COVID-19: a retrospective study in Hangzhou, ChinaJianjiang Qi, Di He, Dagan Yang, et al.
Life Science Alliance|October 19, 2022
A prediction model for COVID-19 liver dysfunction in patients with normal hepatic biochemical parametersJianfeng Bao, Shourong Liu, Xiao Liang, et al.
Clinical Complementary Medicine and Pharmacology|April 15, 2024
Treatment Effects of Integrated TCM and Western Medicine Treatment Scheme on COVID-19: A Single-armed Clinical TrialJianfeng Bao, Zhijun Xie, Shourong Liu, et al.
Gut|August 21, 2025
Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progressionXi Liang, Jinjin Luo, Qian Zhou, et al.
Pageof 7